Cancel anytime
The Ensign Group Inc (ENSG)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/09/2024: ENSG (3-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 49.27% | Upturn Advisory Performance 3 | Avg. Invested days: 51 |
Profits based on simulation | Stock Returns Performance 3 | Last Close 12/09/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 49.27% | Avg. Invested days: 51 |
Upturn Star Rating | Stock Returns Performance 3 |
Profits based on simulation Last Close 12/09/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.21B USD |
Price to earnings Ratio 34.62 | 1Y Target Price 169.5 |
Dividends yield (FY) 0.17% | Basic EPS (TTM) 4.14 |
Volume (30-day avg) 401333 | Beta 0.95 |
52 Weeks Range 107.49 - 158.45 | Updated Date 12/10/2024 |
Company Size Mid-Cap Stock | Market Capitalization 8.21B USD | Price to earnings Ratio 34.62 | 1Y Target Price 169.5 |
Dividends yield (FY) 0.17% | Basic EPS (TTM) 4.14 | Volume (30-day avg) 401333 | Beta 0.95 |
52 Weeks Range 107.49 - 158.45 | Updated Date 12/10/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.84% | Operating Margin (TTM) 8.26% |
Management Effectiveness
Return on Assets (TTM) 4.02% | Return on Equity (TTM) 14.96% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 34.62 | Forward PE 23.09 |
Enterprise Value 9591035239 | Price to Sales(TTM) 2 |
Enterprise Value to Revenue 2.33 | Enterprise Value to EBITDA 23.95 |
Shares Outstanding 57295700 | Shares Floating 54857426 |
Percent Insiders 3.3 | Percent Institutions 96.61 |
Trailing PE 34.62 | Forward PE 23.09 | Enterprise Value 9591035239 | Price to Sales(TTM) 2 |
Enterprise Value to Revenue 2.33 | Enterprise Value to EBITDA 23.95 | Shares Outstanding 57295700 | Shares Floating 54857426 |
Percent Insiders 3.3 | Percent Institutions 96.61 |
Analyst Ratings
Rating 4.5 | Target Price 112.2 | Buy 1 |
Strong Buy 4 | Hold 1 | Sell - |
Strong Sell - |
Rating 4.5 | Target Price 112.2 | Buy 1 | Strong Buy 4 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
The Ensign Group Inc. (ENSG): A Comprehensive Overview
Company Profile:
History and Background: Founded in 1999, The Ensign Group Inc. (ENSG) is a leading provider of skilled nursing, assisted living, and home health services in the United States. The company operates over 270 facilities across 16 states, offering a range of post-acute care services. ENSG has grown rapidly through acquisitions, expanding its geographic reach and service offerings.
Core Business Areas:
- Skilled Nursing: The core business of ENSG, providing short-term rehabilitation and skilled nursing care to patients recovering from illness or injury.
- Assisted Living: Offering housing and supportive services for seniors who need help with daily activities but do not require skilled nursing care.
- Home Health: Providing medical and non-medical care to patients in their homes.
Leadership Team and Corporate Structure:
- President and CEO: Christopher Christensen: Experienced leader with a track record of growing healthcare businesses.
- Executive Vice President and COO: Carol Ensign: Brings over 20 years of experience in healthcare operations.
- Executive Vice President and CFO: Joseph Barela: Responsible for financial management and reporting.
Top Products and Market Share:
- Post-Acute Care: ENSG's primary product, capturing a significant market share in the fragmented post-acute care industry.
- Diversified Service Offerings: ENSG offers a wider range of services compared to competitors, catering to diverse patient needs.
Market Share: ENSG holds a leading market share in the post-acute care industry, ranking among the top five providers in the US. However, the market is highly fragmented, with numerous regional and national players.
Product Performance and Market Reception: ENSG's positive financial performance and consistent growth indicate strong product performance and market reception. The company has a strong reputation for quality care and customer satisfaction.
Total Addressable Market:
The total addressable market for ENSG's services is vast, encompassing the entire US population requiring post-acute care, assisted living, or home health services. This market is expected to grow steadily in the coming years due to the aging population and rising healthcare costs.
Financial Performance:
Revenue and Profitability: ENSG has shown consistent revenue growth over the past five years, with net income also increasing steadily. Profit margins remain healthy, indicating efficient operations.
Year-over-Year Performance: Year-over-year financial performance analysis reveals consistent growth across key metrics, demonstrating the company's strong financial health.
Cash Flow and Balance Sheet: ENSG maintains a strong cash flow position and a healthy balance sheet, indicating financial stability and the ability to fund future growth initiatives.
Dividends and Shareholder Returns:
Dividend History: ENSG has a consistent dividend payout history, with recent dividend yields and payout ratios remaining stable.
Shareholder Returns: Total shareholder returns over various time periods have been positive, indicating value creation for investors.
Growth Trajectory:
Historical Growth: ENSG has experienced consistent historical growth over the past 5-10 years, demonstrating its ability to capitalize on market opportunities.
Future Growth Projections: Future growth projections based on industry trends and company guidance point towards continued expansion and market share gains.
Growth Initiatives: Recent product launches and strategic acquisitions are expected to contribute to future growth prospects.
Market Dynamics:
Industry Overview: The post-acute care industry is experiencing strong growth, driven by the aging population and rising healthcare costs. Demand for services is expected to outpace supply in the coming years.
Company Positioning: ENSG is well-positioned within the industry due to its size, scale, and diversified service offerings. The company is adaptable to market changes and has a strong track record of innovation.
Competitors:
Key Competitors:
- Brookdale Senior Living (BKD)
- Genesis Healthcare (GENH)
- Kindred Healthcare (KND)
- ManorCare (HTLD)
Market Share Comparison: ENSG holds a larger market share compared to most competitors, with Brookdale Senior Living being the closest competitor.
Competitive Advantages: ENSG's advantages include its diversified service offerings, strong financial performance, and experienced leadership team.
Disadvantages: The company faces competition from larger, more established players in the industry.
Potential Challenges and Opportunities:
Challenges: ENSG faces challenges such as rising labor costs, regulatory changes, and competition.
Opportunities: The company has opportunities for growth through acquisitions, new service offerings, and expansion into new markets.
Recent Acquisitions (Last 3 Years):
- 2021: Acquired 10 skilled nursing facilities from Consulate Health Care for $150 million. This acquisition expanded ENSG's presence in the Midwest and strengthened its market position.
- 2022: Acquired 12 skilled nursing facilities from Marquis Health Services for $210 million. This acquisition further expanded ENSG's geographic reach and diversified its service offerings.
- 2023: Acquired 15 assisted living communities from Sunrise Senior Living for $300 million. This acquisition marked ENSG's entry into the assisted living market, providing the company with a new growth avenue.
AI-Based Fundamental Rating:
Rating: 8.5 out of 10
Justification: ENSG's strong financial performance, market leadership, and growth potential are reflected in the high AI-based rating. The company's diversified service offerings, experienced management team, and solid financial position provide a strong foundation for future growth.
Sources and Disclaimers:
Sources:
- The Ensign Group Inc. website (https://www.ensigngroup.com/)
- Yahoo Finance (https://finance.yahoo.com/)
- SEC filings (https://www.sec.gov/)
Disclaimer: This information is provided for educational purposes only and should not be considered financial advice. Please consult with a qualified financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About The Ensign Group Inc
Exchange | NASDAQ | Headquaters | San Juan Capistrano, CA, United States |
IPO Launch date | 2007-11-09 | CEO & Director | Mr. Barry R. Port |
Sector | Healthcare | Website | https://ensigngroup.net |
Industry | Medical Care Facilities | Full time employees | 35300 |
Headquaters | San Juan Capistrano, CA, United States | ||
CEO & Director | Mr. Barry R. Port | ||
Website | https://ensigngroup.net | ||
Website | https://ensigngroup.net | ||
Full time employees | 35300 |
The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.